Previous Close | 998.23 |
1-Year Change | 20.85% |
6-Months Change | 11.66% |
3-Months Change | -6.15% |
Moving Avg (50d) | 1110.96 |
Moving Avg (200d) | 1012.87 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 106.1B |
Beta (3-Years) | 0.57 |
Revenue Growth (ttm) | -4.47% |
Net Profit Margin (ttm) | 30.47% |
Return On Assets (ttm) | 12.41% |
EPS (ttm) | 35.05 |
PE Ratio (ttm) | 28.48 |
Dividend Yield | % |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company branched out into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap.... Wikipedia